Table 3.
Type of recurrence
Type of recurrence | Sorafenib | Control | P value1 |
Hepatic | 8 | 28 | 0.079 |
Extrahepatic | 5 | 12 | 0.707 |
Hepatic + extrahepatic | 2 | 11 | 0.142 |
Overall hepatic recurrence | 10 | 39 | 0.008 |
Overall extrahepatic | 7 | 23 | 0.167 |
Total recurrence | 15 (44.1%) | 51 (75.0%) | 0.002 |
Study group compared with control group.